<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: Medical Xpress news tagged with: medical pharmacology</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Research on immune-cell therapy could strengthen promising melanoma treatment</title>
   	 <description>A new study of genetically modified immune cells by scientists from UCLA and the California Institute of Technology could help improve a promising treatment for melanoma, an often fatal form of skin cancer.</description>
	  <link>http://medicalxpress.com/news/2013-03-immune-cell-therapy-melanoma-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 22 Mar 2013 09:40:05 EST</pubDate>
	 <guid isPermaLink="false">news283163228</guid>
	 
</item>
<item>
     <title>Discovery could increase efficacy of promising cystic fibrosis drug</title>
   	 <description>(Medical Xpress)—A little more than a year after the FDA approved Kalydeco (Vx-770), the first drug of its kind to treat the underlying cause of cystic fibrosis, University of Missouri researchers believe they have found exactly how this drug works and how to improve its effectiveness in the future. Described in the current issue of the Proceedings of the National Academy of Sciences, MU researchers have redefined a key regulatory process in the defective protein responsible for cystic fibrosis that could change the way scientists approach the lethal genetic disease.</description>
	  <link>http://medicalxpress.com/news/2013-03-discovery-efficacy-cystic-fibrosis-drug.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 21 Mar 2013 14:21:27 EST</pubDate>
	 <guid isPermaLink="false">news283094460</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/discoverycou.jpg" width="90" height="90" />
</item>
<item>
     <title>Study could explain why some people get zits and others don't</title>
   	 <description>The bacteria that cause acne live on everyone's skin, yet one in five people is lucky enough to develop only an occasional pimple over a lifetime. What's their secret?</description>
	  <link>http://medicalxpress.com/news/2013-02-people-zits-dont.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 28 Feb 2013 04:30:02 EST</pubDate>
	 <guid isPermaLink="false">news281211221</guid>
	 
</item>
<item>
     <title>Sexual and social behaviour modified by serotonin system drugs</title>
   	 <description>Drugs that bind to specific serotonin receptors in the brain can both improve and impair female sexual function in non-human primates. These are the findings of a study conducted by Leiden PhD candidate Yves Aubert and colleagues at the division of Medical Pharmacology of the Leiden Academic Center for Drug Research (LACDR &amp; LUMC).</description>
	  <link>http://medicalxpress.com/news/2012-12-sexual-social-behaviour-serotonin-drugs.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 12 Dec 2012 08:13:19 EST</pubDate>
	 <guid isPermaLink="false">news274522382</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/imagedisplay.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists identify liposarcoma tumors that respond to chemotherapy</title>
   	 <description>Liposarcoma, the most common type of sarcoma, is an often lethal form of cancer that develops in fat cells. It is particularly deadly, in part, because the tumors are not consistently visible with positron emission tomography (PET) scans that use a common probe called FDG and because they frequently do not respond to chemotherapy.</description>
	  <link>http://medicalxpress.com/news/2012-12-scientists-liposarcoma-tumors-chemotherapy.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 10 Dec 2012 13:34:43 EST</pubDate>
	 <guid isPermaLink="false">news274368875</guid>
	 
</item>
<item>
     <title>Bilirubin can prevent damage from cardiovascular disease</title>
   	 <description>Each year, about 610,000 Americans suffer their first heart attack, according to the Centers for Disease Control and Prevention. Heart attacks and other symptoms of cardiovascular disease can be caused when blockage occurs in the arteries. In a new study from the University of Missouri, a scientist has discovered a natural defense against arterial blockage: bilirubin.</description>
	  <link>http://medicalxpress.com/news/2012-12-bilirubin-cardiovascular-disease.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 06 Dec 2012 10:41:42 EST</pubDate>
	 <guid isPermaLink="false">news274012887</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/bilirubincan.jpg" width="90" height="90" />
</item>
<item>
     <title>Glucose deprivation activates feedback loop that kills cancer cells: study</title>
   	 <description>Compared to normal cells, cancer cells have a prodigious appetite for glucose, the result of a shift in cell metabolism known as aerobic glycolysis or the &quot;Warburg effect.&quot; Researchers focusing on this effect as a possible target for cancer therapies have examined how biochemical signals present in cancer cells regulate the altered metabolic state.</description>
	  <link>http://medicalxpress.com/news/2012-06-glucose-deprivation-feedback-loop-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 26 Jun 2012 14:08:55 EST</pubDate>
	 <guid isPermaLink="false">news259938526</guid>
	 
</item>
<item>
     <title>Second mutation in BRAF-mutated melanoma doesn't contribute to resistance</title>
   	 <description>A second mutation found in the tumors of patients with BRAF-mutated metastatic melanoma does not contribute to resistance to BRAF inhibitor drugs, a finding that runs counter to what scientists expected to be true.</description>
	  <link>http://medicalxpress.com/news/2012-04-mutation-braf-mutated-melanoma-doesnt-contribute.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 01 Apr 2012 14:39:18 EST</pubDate>
	 <guid isPermaLink="false">news252509939</guid>
	 
</item>
<item>
     <title>Scientists uncover mechanism for melanoma drug resistance</title>
   	 <description>Cancer is tough to kill and has many ways of evading the drugs used by oncologists to try and eliminate it.</description>
	  <link>http://medicalxpress.com/news/2012-03-scientists-uncover-mechanism-melanoma-drug.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 06 Mar 2012 11:16:51 EST</pubDate>
	 <guid isPermaLink="false">news250254999</guid>
	 
</item>


</channel>
</rss>
